Literature DB >> 28214611

Biosimilars in the European Union from comparability exercise to real world experience: What we achieved and what we still need to achieve.

Cristina Scavone1, Liberata Sportiello2, Liberato Berrino1, Francesco Rossi1, Annalisa Capuano1.   

Abstract

Mesh：

Substances：

Year:  2017        PMID： 28214611     DOI： 10.1016/j.phrs.2017.02.006

Source DB:  PubMed          Journal:  Pharmacol Res        ISSN： 1043-6618            Impact factor:   7.658


× No keyword cloud information.
  4 in total

1.  Improving titer while maintaining quality of final formulated drug substance via optimization of CHO cell culture conditions in low-iron chemically defined media.

Authors:  Jianlin Xu; Matthew S Rehmann; Xuankuo Xu; Chao Huang; Jun Tian; Nan-Xin Qian; Zheng Jian Li
Journal:  MAbs       Date:  2018-02-20       Impact factor: 5.857

2.  Safety Profile of Anticancer and Immune-Modulating Biotech Drugs Used in a Real World Setting in Campania Region (Italy): BIO-Cam Observational Study.

Authors:  Cristina Scavone; Liberata Sportiello; Maria G Sullo; Carmen Ferrajolo; Rosanna Ruggiero; Maurizio Sessa; Pasquale M Berrino; Gabriella di Mauro; Liberato Berrino; Francesco Rossi; Concetta Rafaniello; Annalisa Capuano
Journal:  Front Pharmacol       Date:  2017-09-06       Impact factor: 5.810

3.  Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database.

Authors:  Rosanna Ruggiero; Federica Fraenza; Cristina Scavone; Gabriella di Mauro; Raffaele Piscitelli; Annamaria Mascolo; Carmen Ferrajolo; Concetta Rafaniello; Liberata Sportiello; Francesco Rossi; Annalisa Capuano
Journal:  Front Pharmacol       Date:  2020-06-09       Impact factor: 5.810

4.  Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study.

Authors:  Cristina Scavone; Maurizio Sessa; Emilio Clementi; Giovanni Corrao; Roberto Leone; Alessandro Mugelli; Francesco Rossi; Edoardo Spina; Annalisa Capuano
Journal:  BioDrugs       Date:  2018-12       Impact factor: 5.807
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.